Cardiovascular Outcomes with Sotagliflozin

To the Editor: In the SOLOIST-WHF trial (Effect of Sotagliflozin on Cardiovascular Events in Patients with Type 2 Diabetes Post Worsening Heart Failure), Bhatt et al. (Jan. 14 issue) 1 report that death from cardiovascular causes and hospitalizations and urgent visits for heart failure (the composit...

Celý popis

Podrobná bibliografia

Vydané v:	The New England journal of medicine Ročník 384; číslo 15; s. 1470 - 1473
Hlavní autori:	Baglioni, Piero, Marchand, Lucien, Villar, Emmanuel, Green, Lisa, Bhatt, Deepak L, Steg, P. Gabriel, Pitt, Bertram
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States Massachusetts Medical Society 15.04.2021
Predmet:	Cardiovascular diseases Congestive heart failure Diabetes Diabetes mellitus (non-insulin dependent) Diabetic Ketoacidosis Glycosides Heart failure Humans Mortality Placebos Renal Insufficiency, Chronic
ISSN:	0028-4793, 1533-4406, 1533-4406
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!